HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nutrition Business Drives DSM Results While Under Construction Into More Focused Groups

Executive Summary

With latest results , Dutch firm notes its “Health, Nutrition & Bioscience (HNB) structure became effective” at the start of the year. Structure includes food and beverage and animal nutrition and health groups as well as human health, nutrition and care.

You may also be interested in...



DSM And Firmenich Merge To Create Nutrition And Fragrance Leader

A global ingredients and fragrance giant with annual sales in excess of €11bn will be created with the merger of Netherlands' DSM and Switzerland's Firmenich.

DSM Reports Strong Supplements Demand As Q1 Sales Rise Double Digits

Royal DSM reports higher demand for supplements and personal-care product ingredients as Q1 sales at its recently-formed Health, Nutrition & Care group grow by 16%.

Biotech Amyris Targeting 150% Consumer Biz Growth In 2022, Up To 40% In Ingredients Arm

The Emeryville, CA-based synthetic biotech firm projects big growth in 2022 as customers seek out “the purest, cleanest and most sustainably sourced natural ingredients in the world.” Amyris’ business is split between Technology Access and Consumer, the latter set to more than double this year.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152219

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel